Loading…
Screening for Cervical Cancer and Human Papillomavirus Vaccination in Israel: Recommendations
[...]mortality rates from cervical cancer and rates of cervical intraepithelial neoplasia (CIN) and condyloma acuminata are similar to those in countries with higher cervical cancer incidence rates (Fig. 1). Because of this low burden of cervical cancer, health policy makers in Israel decided to bas...
Saved in:
Published in: | Vaccine 2013-11, Vol.31, p.I58-I60 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [...]mortality rates from cervical cancer and rates of cervical intraepithelial neoplasia (CIN) and condyloma acuminata are similar to those in countries with higher cervical cancer incidence rates (Fig. 1). Because of this low burden of cervical cancer, health policy makers in Israel decided to base cervical cancer prevention on opportunistic screening, where every woman can have a Pap test smear every 3years free of charge between ages of 35 and 54years. The implementation of an organized national cervical screening program, similar to Israel's current call and recall breast and colon cancer screening programs, tends to be more efficient, balances health inequalities and usually achieves higher coverage. [...]the first step that Israel should face is to improve by means of an organized effort the current screening coverage in unscreened and underscreened women, in whom most cervical cancer cases are concentrated. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2013.07.048 |